View Older Stories View More Recent Stories

Apr 1, 2020 12:06PM iTeos Therapeutics Closes $125 Million Series B2 Financing
Mar 26, 2020 07:00AM SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Mar 24, 2020 07:30AM Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
Mar 24, 2020 07:30AM Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
Mar 13, 2020 05:19PM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 11, 2020 08:01PM Form 3 IMARA Inc. For: Mar 11 Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 11, 2020 04:05PM Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results
Mar 5, 2020 04:32PM Form SC 13G Verastem, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 3, 2020 08:30AM Akouos Closes $105 Million Series B Financing
Feb 28, 2020 06:15AM Verastem (VSTM) Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
Feb 28, 2020 06:00AM Verastem Oncology Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
Feb 27, 2020 12:00PM Biotech Veteran Jean-Paul Mangeolle Joins TeraPore Technologies Board of Directors
Feb 27, 2020 06:00AM First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
Feb 27, 2020 06:00AM First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
Feb 18, 2020 08:30AM CANbridge Pharmaceuticals Completes US$98 Million Series D Financing
Feb 15, 2020 01:21AM Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 15, 2020 01:02AM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 14, 2020 05:41PM Form SC 13G/A scPharmaceuticals Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:28PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:28PM Form SC 13G RELMADA THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:24PM Form SC 13G Prevail Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:23PM Form SC 13G/A Myovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:23PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:22PM Form SC 13G X4 Pharmaceuticals, Inc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:22PM Form SC 13G Retrophin, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 05:22PM Form SC 13G/A Eiger BioPharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 04:53PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 04:53PM Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 04:53PM Form SC 13G/A Phathom Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 04:53PM Form SC 13G/A ARVINAS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 04:53PM Form SC 13G ChemoCentryx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 14, 2020 04:53PM Form SC 13G ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 5, 2020 05:22PM Form SC 13D Black Diamond Therapeuti Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 29, 2020 04:05PM Lyra Therapeutics Completes $30 Million Series C Financing
Jan 27, 2020 02:00AM Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases
Jan 17, 2020 06:17AM Iterum Therapeutics (ITRM) Announces $52 Million Private Placement
Jan 17, 2020 06:15AM Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
Jan 17, 2020 06:15AM Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
Jan 10, 2020 11:00AM Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology
Jan 9, 2020 08:00AM Nkarta Therapeutics to Present at the J.P. Morgan Healthcare Conference
Jan 7, 2020 08:05AM Cerebral Therapeutics Completes $35 Million Series B Financing
Jan 7, 2020 08:00AM Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People
Dec 19, 2019 07:00AM FORMA Therapeutics Announces Closing of $100 Million Series D Financing
Dec 9, 2019 08:00AM Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development
Dec 5, 2019 08:17AM Black Diamond Therapeutics Closes $85 Million Series C Financing
Nov 21, 2019 07:00AM Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer
Nov 18, 2019 05:16PM Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Nov 14, 2019 04:34PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 13, 2019 05:06PM Form SC 13D 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 11, 2019 11:05AM Chemical & Engineering News Names Frontier Medicines One of its 10 Chemistry Start-Ups to Watch
View More Recent Stories View Older Stories